When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AMGN - EC approves Evenity for osteoporosis in postmenopausal women
Amgen Inc.
Amgen (NASDAQ:AMGN) and UCB (OTCPK:UCBJY) announces that the European Commission (EC) has granted marketing authorization for EVENITY (romosozumab) for the treatment of severe osteoporosis in postmenopausal women at high risk of fracture.
More news on: Amgen Inc., UCB SA, UCB SA, Healthcare stocks news,